Invivo Capital Partners
Venture capitalBarcelona · Pre-Seed–Series A · 11 people tracked
Investment thesis
Invivo Partners backs early-stage companies in biotechnology and at the intersection of AI and deeptech, with a focus on innovative drug development, advanced therapies, and synthetic biology. It invests at pre-seed (company creation) and seed stages during the preclinical phase, and directly at Series A for companies one to two years from First-in-Human trials. Initial checks range from €2-4M with follow-ons up to €10M per company after milestones are met. The firm targets European companies with special emphasis on Spanish opportunities, aiming to become a leading player in Europe's biotech industry by leveraging its understanding of Technology Transfer and market trends.
Source: firm website, verified Aug 7, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 11 of 28 portfolio companiesBiotech ×8Healthtech ×6Deep Tech ×2GovTech ×2Medical Devices ×2AI & Machine Learning ×1Fintech ×1Impact & Social Good ×1
HQs:Spain×5United States×1
Investments · 28 tracked
founders shown can be your intro pathBiotech firm specializing in RNA interference (RNAi) therapeutics
Biotech company developing biopharmaceuticals
ARA is a Catalan-language news publication offering coverage of international, national, and cultural affairs, along with opinion and special editorial initiatives.
Media & Entertainment
Arthex Biotech develops an investigational anti-miR therapeutic targeting an upregulated miRNA for the treatment of myotonic dystrophy, aiming to address the root cause of the disease.
BiotechMedical Devices
Official municipal website of the city of Barcelona, providing residents with access to public services, administrative procedures, cultural agenda, and city information.
GovTechBarcelona, ES
Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.
BiotechHealthtechAlbuquerque, US
Thomas Duensing(Executive Officer)Dennis Hynson(Executive Officer)Jack T. Ball(Director)J. Michael Schafer(Director)Janette Phi(Executive Officer)Bo E.H. Saxberg(Director)
Instituto de Crédito Oficial (ICO) is Spain's state-owned finance institution providing loans and guarantee lines to self-employed workers, SMEs, and companies, including financing for exports, internationalization, and sustainable projects.
FintechGovTechImpact & Social Good
OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases.
BiotechHealthtech
Pablo Menéndez(Scientific Founder)
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.
BiotechDeep TechHealthtechMedical DevicesBarcelona, ES
Dr. Laura Soucek(Co-founder and CEO)Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))
Advanced gene and cell therapies developer
Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes.
BiotechHealthtechLongevity
Telum Therapeutics is a drug discovery biotechnology company that uses synthetic biology and AI to engineer phage lytic enzymes (enzybiotics) as alternatives to traditional antibiotics.
AI & Machine LearningBiotechHealthtechNoáin, ES
Exits · 2
IPOs and acquisitions across the tracked portfolioAlnylam PharmaceuticalsNASDAQ: ALNYBioCryst PharmaceuticalsNASDAQ: BCRX
Frequently asked questions
- What stage does Invivo Capital Partners invest at?
- Invivo Capital Partners invests at the Pre-Seed, Seed, Series A stages.
- What is Invivo Capital Partners's typical check size?
- Invivo Capital Partners typically writes checks of $2.2M – $4.3M.
- What sectors does Invivo Capital Partners focus on?
- Invivo Capital Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Invivo Capital Partners located?
- Invivo Capital Partners is headquartered in Barcelona, ES.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
SV Tech Ventures is a Palo Alto-based venture capital firm investing in early-stage, high-tech startups, offering hands-on support with strategy, product, fundraising, and hiring across its funds.